Overall, while GDF15 exhibits therapeutic potential for treatment of T2DM, particularly due to its ability to enhance insulin sensitivity and glucose tolerance independently of weight loss, much remains to be understood. This evidence concerns the gene INS and type 2 diabetes mellitus.